Human isolates of Salmonella enterica serovars Hadar, Kentucky, Virchow, Schwarzengrund, and the monophasic variant of S. Typhimurium, Salmonella enterica subsp. enterica serovar 4,5,12:i:؊ were examined for mutations within the quinolone resistance target genes gyrA, gyrB, parC, and parE and for plasmid-mediated resistance genes. Differences were observed among the serovars. A novel variant of qnrD, qnrD2, was detected in an S. Hadar isolate.
(CAC TTA TGC ATG GGA CGG), qnrB_seq_R (R stands for reverse) (CGG ATT TGA CGC ATA ACC), qnrS1_orf_f (GTT GTA ATG TGT TGAT GTA ACA GG), and qnrS1_orf_r (CCC TAT GTC TAT TAT TGC AAG G) were used. Conjugational transfer was performed by a standard broth mating method, using Escherichia coli strain HK225 as the recipient (17) . Cloning using the vector plasmid pUC19 and electrocompetent E. coli ATCC 25922 cells and sequencing were performed using the conditions listed in Table S1 in the supplemental material. Susceptibility was determined using Etest strips (bioMérieux, Marcy l'Etoile, France) and the disk diffusion and microdilution methods (18) . For selected isolates, microdilution was performed in the absence and presence of the efflux pump inhibitor phenylalaninearginine-␤-naphthylamide (PA␤N) at a final concentration of 40 g/ml.
The results of this study are summarized in Table 1 . Target gene mutations were not distributed equally among the serovars. Among S. Hadar isolates, alterations in GyrA appeared most commonly (90%) as single-amino-acid substitutions. Only isolates containing the substitution Ser80¡Ile in ParC, i.e., 15 S. Kentucky isolates and one S. Hadar isolate (N10-1465) were resistant to ciprofloxacin according to CLSI criteria (18) . As no mutations in parC were detected in S. Virchow, S. Schwarzengrund, or S. enterica serovar 4,5,12:i:Ϫ, this finding indicates that topoisomerase IV mutations are possibly characteristic of S. Kentucky and may occur more frequently than previously understood (19) , although it may be due to the fact that most of the isolates belong to the same large cluster (9) .
All the ciprofloxacin-resistant S. Kentucky isolates contained the substitution Ser83¡Phe in GyrA, and six isolates e Isolates belonging to a large cluster (9) . f Isolates associated with travel to Thailand (10).
(N05-1087, N06-0062, N06-1493, N06-1616, N07-0953, and N08-1057) contained mutations in codon Asp87, which has been reported to be useful for tracking the geographical origin of the pandemic ciprofloxacin-resistant S. Kentucky strain ST198 (20) .
All S. Virchow isolates uniformly revealed an Asp87¡Tyr substitution in GyrA. As all but two (N05-2379 and N0-2461) of the isolates belong to a large cluster found to be disseminated internationally (10) , this suggests that S. Virchow maintains a highly established quinolone target gene resistance genotype. Interestingly, this serovar contained three of the four detected plasmid-mediated resistance genes (two qnrS1 genes and one qnrB2 gene). Isolates N06-978 and N07-0090 harboring qnrS2 plasmids belong, together with a qnrS2-harboring S. Virchow isolate described previously (6) , to a subcluster associated with travel to Thailand (10) .
One S. Hadar isolate (N08-2312) harbored the plasmid-mediated quinolone resistance gene qnrD2, a novel variant of qnrD1 (16) . Although differing from qnrD1 by two amino acid exchanges (Ile189¡Thr and Leu202¡Phe), no effect on resistance levels to quinolones was detected when comparing isogenic E. coli strains containing cloned qnrD1 and qnrD2, respectively. The MICs of nalidixic acid and ciprofloxacin were1 g/ml and 0.03 g/ml, respectively, in both cases (see Table S2 in the supplemental material). Sequencing of the complete plasmid containing qnrD2 revealed a 4,268-bp plasmid (pQnrD2) with 99% homology to p2007057 containing qnrD1 (16) . Apart from the qnrD gene, this plasmid contains 4 open reading frames of unknown function. None of the control strains contained target gene mutations or PMQR genes.
Conjugational transfer was successful for S. Virchow N06-0978 containing qnrS1, but not for the other isolates containing qnrD2, qnrS1, and qnrB2.
As expected (21) , the efflux pump inhibitor PA␤N was not sufficient to restore antibiotic susceptibility, although it caused a 32-fold reduction of nalidixic acid MICs in 12.5% of the tested isolates (Table 1) .
This study documents quinolone resistance mutations in different Salmonella serovars, which may be useful for understanding the origins and routes of dissemination of resistant isolates.
Nucleotide sequence accession numbers. The nucleotide sequences of qnrD2 and pQnrD2 have been deposited at GenBank under accession numbers KF055448 and KJ158441, respectively.
